Recent director dealings and insider transactions at Boston Scientific Corporation (BSX),
from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
Date
Insider
Type
Shares
2026-08-25
Morano Susan E
BUY
2,040
2026-08-11
Woodworth Emily
BUY
2,930
2026-08-10
Monson Jonathan
BUY
9,908
2026-08-05
Habiger David C
BUY
2,100
2026-08-04
Habiger David C
BUY
140
2026-08-03
Mahoney Michael F
BUY
22,119
2026-08-03
Mahoney Michael F
BUY
186,240
2026-08-03
Habiger David C
BUY
1,042
2026-07-31
Fitzgerald Joseph Michael
BUY
64,198
2026-07-31
Ludwig Edward J
BUY
5,000
Valuation
P/E RatioN/A
Market CapN/A
Beta0.568
Dividend/yrNone
52W High$109.50
52W Low$42.20
52-Week Range
$42.20Now$109.50
8% through annual range
From 52W High−56.3%
From 52W Low+13.3%
📖 Plain English Summary
Boston Scientific Corporation is at 8% of its 52-week range. Beta 0.568 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for BSX🟢 Bullish⬜ Neutral🔴 Bearish
🤖
DipBuster AI Analysis — BSX
Heuristic · balance sheet, insider filings, price data, academic research
Boston Scientific Corporation — DipBuster Score 54/100
Graham value assessment, NCAV analysis, price zones...
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interv…
